Evidence map›Paper›PMID 32481703›Full record

ReviewLife (Basel, Switzerland)2020

Distinctive Features of PipX, a Unique Signaling Protein of Cyanobacteria.

Jose I Labella, Raquel Cantos, Paloma Salinas, Javier Espinosa, Asunción Contreras

Open access · goldAbstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Suppressor analysis inFrontiers in microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jose I LabellaDpto. Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, 03690, Spain.
Raquel CantosDpto. Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, 03690, Spain.
Paloma SalinasDpto. Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, 03690, Spain.
Javier EspinosaDpto. Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, 03690, Spain.
Asunción ContrerasDpto. Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, 03690, Spain.
University of Alicante · ES

Funding

Generalitat Valenciana PROMETEO/2017/129Universidad de Alicante FPUUA59Universidad de Alicante UAUSTI19-06Universidad de Alicante VIGROB-126/19
6 · The paper itself

Abstract

PipX is a unique cyanobacterial protein identified by its ability to bind to PII and NtcA, two key regulators involved in the integration of signals of the nitrogen/carbon and energy status, with a tremendous impact on nitrogen assimilation and gene expression in cyanobacteria. PipX provides a mechanistic link between PII, the most widely distributed signaling protein, and NtcA, a global transcriptional regulator of cyanobacteria. PII, required for cell survival unless PipX is inactivated or down-regulated, functions by protein-protein interactions with transcriptional regulators, transporters, and enzymes. In addition, PipX appears to be involved in a wider signaling network, supported by the following observations: (i) PII-PipX complexes interact with PlmA, an as yet poorly characterized transcriptional regulator also restricted to cyanobacteria; (ii) the

Indexed as

cyanobacteriainteraction networknitrogen regulationsignal transductionsynteny network

Identifiers

PMID32481703
PMCPMC7344720
OpenAlexW3031711012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.